Search Ontology:
ChEBI

mocetinostat

Term ID
CHEBI:197437
Synonyms
  • MG 0103
  • MGCD 0103
  • MGCD-0103
  • MGCD0103
  • mocetinostat
  • mocetinostatum
  • N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide
  • N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide
Definition
A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11).
References
  • cas:726169-73-9
  • drugbank:DB11830
  • hmdb:HMDB0254820
  • kegg.drug:D09641
  • lincs.smallmolecule:LSM-5344
  • pubmed:17621879
  • pubmed:21554162
  • pubmed:22033282
  • pubmed:24588344
  • pubmed:26357656
  • pubmed:26464683
  • pubmed:28440559
  • pubmed:29186204
  • pubmed:29238851
  • pubmed:29978554
  • pubmed:30344659
  • pubmed:30473623
  • pubmed:30551546
  • pubmed:30570744
  • pubmed:31534435
  • pubmed:32194803
  • pubmed:32373984
  • pubmed:34002805
  • pubmed:34565105
  • pubmed:34983914
  • pubmed:35317122
  • pubmed:35678233
  • pubmed:36642966
  • pubmed:36890020
  • pubmed:37681413
  • pubmed:37759078
  • wikipedia.en:Mocetinostat
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from mocetinostat
Phenotype where environments contain mocetinostat
Phenotype modified by environments containing mocetinostat
Phenotype affecting mocetinostat
Human Disease Model